Annie Mitsak, Ph.D.

Partner atCure VenturesMassachusetts

Annie Mitsak is an investment professional at Cure Ventures. She has experience in academic licensing and venture investing within the biotechnology sector.

What Annie can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Email the firm[email protected]The firm's own inbox for founders.

Career

  1. MIT’s Technology Licensing Office · Associate Licensing Officer
  2. Nelsen Biomedical · independent management consultant
  3. Omega Funds
  4. Cure Ventures · Partner
    Now

Investments named in public bios

Trevi TherapeuticsAnjarium BiosciencesCheckmate PharmaceuticalsIkena OncologyPhotys TherapeuticsRectify PharmaceuticalsScorpion Therapeutics

Focus

oncologygene therapyRNA therapeuticsimmunologyrare diseases

Education

University of Virginia, B.S. in Biomedical EngineeringUniversity of Michigan, Ph.D. in Biomedical Engineering

Also at Cure Ventures

Partners like Annie

At firms with a similar stage, sector and check size.

Alert me when Cure Ventures is active

One email when Annie's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Annie Mitsak, Ph.D.?

Annie Mitsak is an investment professional at Cure Ventures. She has experience in academic licensing and venture investing within the biotechnology sector.

How much does Annie Mitsak, Ph.D. invest?

Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Annie Mitsak, Ph.D.?

Email [email protected], the firm's inbox for founders, and name Annie in the subject. A warm intro from a founder Cure Ventures backed works better.

What did Annie Mitsak, Ph.D. do before Cure Ventures?

Associate Licensing Officer at MIT’s Technology Licensing Office; independent management consultant at Nelsen Biomedical; Omega Funds.

Last updated 2026-10-15. Is this you? Ask for a correction.